Shelley M Herbrich (Shelley Herbrich)

Years Active: 2018-2022
Publications (10 Years): 3

University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences

United States

Graduate Student :: Clinical and Translational Oncology

University of Texas MD Anderson Cancer Center

United States

Graduate student :: Leukemia

Publications

Sankaranarayan Kannan, Mary E Irwin, Shelley M Herbrich, Tiewei Cheng, LaNisha L Patterson, Marisa J L Aitken, Kapil Bhalla, M James You, Marina Konopleva, Patrick A Zweidler-McKay, Joya Chandra
Targeting the NRF2/HO-1 Antioxidant Pathway in FLT3-ITD-Positive AML Enhances Therapy Efficacy. Antioxidants (Basel, Switzerland) 11 (4) (2022)
Shelley M Herbrich, Natalia Baran, Tianyu Cai, Connie Weng, Marisa J L Aitken, Sean M Post, Jared Henderson, Chunhua Shi, Guillame Richard-Carpentier, Guy Sauvageau, Keith Baggerly, Gheath Al-Atrash, R Eric Davis, Naval Daver, Dongxing Zha, Marina Konopleva
Overexpression of CD200 is a Stem Cell-Specific Mechanism of Immune Evasion in AML. Journal for immunotherapy of cancer 9 (7) (2022)
Shelley M Herbrich, Keith A Baggerly, Marina Y Konopleva
Refining statistics clarifies leukaemic stem cell genomics. British journal of haematology 185 (5) (2018)

Shelley M Herbrich.css-eqlu8i{font-size:small;padding-left:4px;} (Shelley Herbrich)